ARFFX
Price
$15.28
Change
-$0.01 (-0.07%)
Updated
May 22 closing price
Net Assets
60.7M
JVMTX
Price
$27.21
Change
-$0.03 (-0.11%)
Updated
May 22 closing price
Net Assets
21.79B
Interact to see
Advertisement

ARFFX vs JVMTX

Header iconARFFX vs JVMTX Comparison
Open Charts ARFFX vs JVMTXBanner chart's image
Ariel Focus Investor
Price$15.28
Change-$0.01 (-0.07%)
VolumeN/A
Net Assets60.7M
JHancock Disciplined Value Mid Cap R4
Price$27.21
Change-$0.03 (-0.11%)
VolumeN/A
Net Assets21.79B
ARFFX vs JVMTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARFFX vs. JVMTX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARFFX is a Buy and JVMTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 21.8B vs. ARFFX (60.7M). ARFFX pays higher dividends than JVMTX: ARFFX (1.17) vs JVMTX (0.71). ARFFX was incepted earlier than JVMTX: ARFFX (20 years) vs JVMTX (12 years). ARFFX (1.18) is less costly to investors than JVMTX (1.11). JVMTX is a more actively managed with annual turnover of: 47.00 vs. ARFFX (19.00). JVMTX has a lower initial minimum investment than ARFFX: JVMTX (0) vs ARFFX (1000). ARFFX annual gain was more profitable for investors over the last year : -0.27 vs. JVMTX (-4.36). JVMTX return over 5 years is better than : 61.31 vs. ARFFX (50.34).
ARFFXJVMTXARFFX / JVMTX
Total Expense Ratio1.001.00100%
Annual Report Gross Expense Ratio1.181.11106%
Fund Existence20 years12 years-
Gain YTD-5.7343.456-166%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets60.7M21.8B0%
Annual Yield % from dividends1.170.71165%
Returns for 1 year-0.27-4.366%
Returns for 3 years-4.0312.71-32%
Returns for 5 years50.3461.3182%
Returns for 10 years18.2935.6451%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XTJA27.94-0.37
-1.29%
Innovator US Equity Acclrtd Pls ETF Jan
USSE30.82-0.60
-1.91%
Segall Bryant & Hamill Select Equity ETF
CHI10.20-0.21
-2.02%
Calamos Convertible Opportunities and Income Fund
EPRF17.32-0.36
-2.04%
Innovator S&P Investment Grade Prfrd ETF
IBB121.69-2.98
-2.39%
iShares Biotechnology ETF